{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:46:04Z","timestamp":1747205164817,"version":"3.40.5"},"posted":{"date-parts":[[2024,4,10]]},"group-title":"In Review","reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,2,27]]},"abstract":"<title>Abstract<\/title>\n        <p>Multi-platform mutational, proteomic, and metabolomic spatial mapping was used on the whole-organ scale to identify the molecular evolution of bladder cancer from mucosal field effects. We identified complex proteomic and metabolomic dysregulations in microscopically normal areas of bladder mucosa adjacent to dysplasia and carcinoma <italic>in situ<\/italic>. The mutational landscape developed in a background of complex defects of protein homeostasis which included dysregulated nucleocytoplasmic transport, splicesome, ribosome biogenesis, and peroxisome. These changes were combined with altered urothelial differentiation which involved lipid metabolism and protein degradations controlled by PPAR. The complex alterations of proteome were accompanied by dysregulation of gluco-lipid energy-related metabolism. The analysis of mutational landscape identified three types of mutations based on their geographic distribution and variant allele frequencies. The most common were low frequency \u03b1 mutations restricted to individual mucosal samples. The two other groups of mutations were associated with clonal expansion. The first of this group referred to as \u03b2 mutations occurred at low frequencies across the mucosa. The second of this group called \u03b3 mutations increased in frequency with disease progression. Modeling of the mutations revealed that carcinogenesis may span nearly 30 years and can be divided into dormant and progressive phases. The \u03b1 mutations developed gradually in the dormant phase. The progressive phase lasted approximately five years and was signified by the advent of \u03b2 mutations, but it was driven by \u03b3 mutations which developed during the last 2\u20133 years of disease progression to invasive cancer. Our study indicates that the understanding of complex alterations involving mucosal microenvironment initiating bladder carcinogenesis can be inferred from the multi-platform whole-organ mapping.<\/p>","DOI":"10.21203\/rs.3.rs-3994376\/v1","type":"posted-content","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T16:19:36Z","timestamp":1712765976000},"source":"Crossref","is-referenced-by-count":0,"title":["Inferring Bladder Cancer Evolution from Mucosal Field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic Mapping"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-9173","authenticated-orcid":false,"given":"Bogdan","family":"Czerniak","sequence":"first","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangkyou","family":"Lee","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1521-7977","authenticated-orcid":false,"given":"Sung Yun","family":"Jung","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-9821","authenticated-orcid":false,"given":"Pawel","family":"Kus","sequence":"additional","affiliation":[{"name":"Silesian Univerity of Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Bondaruk","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Lee","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Jaksik","sequence":"additional","affiliation":[{"name":"Silesian University of Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagireddy","family":"Putluri","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khanh","family":"Dinh","sequence":"additional","affiliation":[{"name":"Irving Institute for Cancer Dynamics, Columbia University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cogdell","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqin","family":"Chen","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishan","family":"Wang","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiansong","family":"Chen","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neema","family":"Nevai","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Dinney","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Mendelsohn","sequence":"additional","affiliation":[{"name":"Columbia University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"McConkey","sequence":"additional","affiliation":[{"name":"Johns Hopkins Greenberg Bladder Cancer Institute, Johns Hopkins University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Behringer","sequence":"additional","affiliation":[{"name":"University of Texas M. D. Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Guo","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wei","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Kimmel","sequence":"additional","affiliation":[{"name":"Rice University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1158\/0008-5472.CAN-20-1956","article-title":"Field Carcinogenesis in Cancer Evolution: What the Cell Is Going On?","volume":"80","author":"Sinjab A","year":"2020","unstructured":"Sinjab A, Han G, Wang L, Kadara H (2020) Field Carcinogenesis in Cancer Evolution: What the Cell Is Going On? Cancer Res 80:4888\u20134891. 10.1158\/0008-5472.CAN-20-1956","journal-title":"Cancer Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrc.2017.102","article-title":"An evolutionary perspective on field cancerization","volume":"18","author":"Curtius K","year":"2018","unstructured":"Curtius K, Wright NA, Graham TA (2018) An evolutionary perspective on field cancerization. Nat Rev Cancer 18:19\u201332. 10.1038\/nrc.2017.102","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104551","author":"Bondaruk J","year":"2022","unstructured":"Bondaruk J, Jaksik R, Wang Z, Cogdell D, Lee S, Chen Y, Dinh KN, Majewski T, Zhang L, Cao S et al (2022) The origin of bladder cancer from mucosal field effects. iScience 25, 104551. 10.1016\/j.isci.2022.104551"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.celrep.2019.01.095","article-title":"Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis","volume":"26","author":"Majewski T","year":"2019","unstructured":"Majewski T, Yao H, Bondaruk J, Chung W, Lee S, Lee JG, Zhang S, Cogdell D, Yang G, Choi W et al (2019) Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis. Cell Rep 26:2241\u20132256e2244. 10.1016\/j.celrep.2019.01.095","journal-title":"Cell Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1126\/science.aba8347","article-title":"Extensive heterogeneity in somatic mutation and selection in the human bladder","volume":"370","author":"Lawson ARJ","year":"2020","unstructured":"Lawson ARJ, Abascal F, Coorens THH, Hooks Y, O'Neill L, Latimer C, Raine K, Sanders MA, Warren AY, Mahbubani KTA et al (2020) Extensive heterogeneity in somatic mutation and selection in the human bladder. Science 370:75\u201382. 10.1126\/science.aba8347","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"253264","DOI":"10.3233\/BLC-200282","article-title":"Mutational analysis of field cancerization in bladder cancer","volume":"6","author":"Strandgaard T","year":"2020","unstructured":"Strandgaard T, Lamy NI, Christensen P, Borg E, Thomsen H, Thomsen MBH, Jensen M, Bjerggaard Jensen JB, Dyrskj\u00f8t J, Dyrskjot L L (2020) Mutational analysis of field cancerization in bladder cancer. Bladder Cancer 6:253264","journal-title":"Bladder Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"11702","DOI":"10.1038\/s41598-017-11291-0","article-title":"Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer","volume":"7","author":"Thomsen MBH","year":"2017","unstructured":"Thomsen MBH, Nordentoft I, Lamy P, Vang S, Reinert L, Mapendano CK, Hoyer S, Orntoft TF, Jensen JB, Dyrskjot L (2017) Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer. Sci Rep 7:11702. 10.1038\/s41598-017-11291-0","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2023.07.014","article-title":"Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer","volume":"85","author":"Strandgaard T","year":"2024","unstructured":"Strandgaard T, Nordentoft I, Birkenkamp-Demtroder K, Salminen L, Prip F, Rasmussen J, Andreasen TG, Lindskrog SV, Christensen E, Lamy P et al (2024) Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer. Eur Urol 85:82\u201392. 10.1016\/j.eururo.2023.07.014","journal-title":"Eur Urol"},{"key":"ref9","first-page":"129","article-title":"Statistical Inference for the Evolutionary History of Cancer Genomes","volume":"35","author":"Dinh KN","year":"2020","unstructured":"Dinh KN, Kimmel JR, Lambert M, Tavare A S (2020) Statistical Inference for the Evolutionary History of Cancer Genomes. Stat Sci 35:129\u2013144","journal-title":"Stat Sci"},{"year":"2010","author":"Lange K","key":"ref10","unstructured":"Lange K (2010) Branching Processes. In Applied Probability, (Springer), pp. 217\u2013245"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914938","author":"Davalieva K","year":"2023","unstructured":"Davalieva K, Kiprijanovska S, Ivanovski O, Trifunovski A, Saidi S, Dimovski A, Popov Z (2023) Proteomics Profiling of Bladder Cancer Tissues from Early to Advanced Stages Reveals NNMT and GALK1 as Biomarkers for Early Detection and Prognosis of BCa. Int J Mol Sci 24. 10.3390\/ijms241914938"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41139-3","article-title":"Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ","volume":"14","author":"Yao Z","year":"2023","unstructured":"Yao Z, Xu N, Shang G, Wang H, Tao H, Wang Y, Qin Z, Tan S, Feng J, Zhu J et al (2023) Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ. Nat Commun 14. 10.1038\/s41467-023-41139-3","journal-title":"Nat Commun"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-023-09419-8","article-title":"Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity","volume":"20","author":"Tabaei S","year":"2023","unstructured":"Tabaei S, Haghshenas MR, Ariafar A, Gilany K, Stensballe A, Farjadian S, Ghaderi A (2023) Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity. Clin Proteom 20. 10.1186\/s12014-023-09419-8","journal-title":"Clin Proteom"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov LB","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL et al (2013) Signatures of mutational processes in human cancer. Nature 500:415\u2013421. 10.1038\/nature12477","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.urolonc.2008.11.002","article-title":"Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer","volume":"27","author":"Inamoto T","year":"2009","unstructured":"Inamoto T, Shah JB, Kamat AM (2009) Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer. Urol Oncol 27:585\u2013591. 10.1016\/j.urolonc.2008.11.002","journal-title":"Urol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clnu.2023.12.005","article-title":"Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression","volume":"43","author":"Li Y","year":"2024","unstructured":"Li Y, Pan Y, Zhao X, Wu S, Li F, Wang Y, Liu B, Zhang Y, Gao X, Wang Y, Zhou H (2024) Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression. Clin Nutr 43:332\u2013345. 10.1016\/j.clnu.2023.12.005","journal-title":"Clin Nutr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2011342118","author":"Damaghi M","year":"2021","unstructured":"Damaghi M, West J, Robertson-Tessi M, Xu L, Ferrall-Fairbanks MC, Stewart PA, Persi E, Fridley BL, Altrock PM, Gatenby RA et al (2021) The harsh microenvironment in early breast cancer selects for a Warburg phenotype. Proc Natl Acad Sci U S A 118. 10.1073\/pnas.2011342118"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153942","author":"Gnocchi D","year":"2023","unstructured":"Gnocchi D, Nikolic D, Paparella RR, Sabba C, Mazzocca A (2023) Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis. Cancers (Basel) 15. 10.3390\/cancers15153942"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.biochi.2023.01.005","article-title":"Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance","volume":"208","author":"Gnocchi D","year":"2023","unstructured":"Gnocchi D, Sabba C, Mazzocca A (2023) Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance. Biochimie 208:180\u2013185. 10.1016\/j.biochi.2023.01.005","journal-title":"Biochimie"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1073\/pnas.1816391116","article-title":"Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways","volume":"116","author":"Jia D","year":"2019","unstructured":"Jia D, Lu M, Jung KH, Park JH, Yu L, Onuchic JN, Kaipparettu BA, Levine H (2019) Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways. Proc Natl Acad Sci U S A 116:3909\u20133918. 10.1073\/pnas.1816391116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14789450.2019.1583105","article-title":"Recent advances in the metabolomic study of bladder cancer","volume":"16","author":"Amara CS","year":"2019","unstructured":"Amara CS, Vantaku V, Lotan Y, Putluri N (2019) Recent advances in the metabolomic study of bladder cancer. Expert Rev Proteom 16:315\u2013324. 10.1080\/14789450.2019.1583105","journal-title":"Expert Rev Proteom"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12060544","author":"Kami Reddy KR","year":"2022","unstructured":"Kami Reddy KR, Piyarathna DWB, Kamal AHM, Putluri V, Ravi SS, Bollag RJ, Terris MK, Lotan Y, Putluri N (2022) Lipidomic Profiling Identifies a Novel Lipid Signature Associated with Ethnicity-Specific Disparity of Bladder Cancer. Metabolites 12. 10.3390\/metabo12060544"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.euf.2017.04.005","article-title":"Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder","volume":"4","author":"Piyarathna DWB","year":"2018","unstructured":"Piyarathna DWB, Rajendiran TM, Putluri V, Vantaku V, Soni T, von Rundstedt FC, Donepudi SR, Jin F, Maity S, Ambati CR et al (2018) Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder. Eur Urol Focus 4:907\u2013915. 10.1016\/j.euf.2017.04.005","journal-title":"Eur Urol Focus"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/jnci\/94.17.1320","article-title":"Amplification\/overexpression of a mitotic kinase gene in human bladder cancer","volume":"94","author":"Sen S","year":"2002","unstructured":"Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC et al (2002) Amplification\/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 94:1320\u20131329. 10.1093\/jnci\/94.17.1320","journal-title":"J Natl Cancer Inst"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"13732","DOI":"10.1073\/pnas.0701771104","article-title":"Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia","volume":"104","author":"Lee S","year":"2007","unstructured":"Lee S, Jeong J, Majewski T, Scherer SE, Kim MS, Tuziak T, Tang KS, Baggerly K, Grossman HB, Zhou JH et al (2007) Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia. Proc Natl Acad Sci U S A 104:13732\u201313737. 10.1073\/pnas.0701771104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","volume-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","author":"Cancer IAfRo","year":"2016","unstructured":"Cancer IAfRo, Moch H, Reuter VE (2016) WHO Classification of Tumours of the Urinary System and Male Genital Organs. International Agency for Research on Cancer"},{"year":"2016","author":"Brierley JD","key":"ref27","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2016) TNM Classification of Malignant Tumours, 8th Edition (Wiley-Blackwell)"},{"key":"ref28","first-page":"2860","article-title":"Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization","volume":"57","author":"Richter J","year":"1997","unstructured":"Richter J, Jiang F, Gorog JP, Sartorius G, Egenter C, Gasser TC, Moch H, Mihatsch MJ, Sauter G (1997) Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 57:2860\u20132864","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini Y","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J R Stat Soc B 57:289\u2013300. 10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J R Stat Soc B"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1017\/9781316104477","volume-title":"Lectures on the Poisson Process","author":"Last G","year":"2017","unstructured":"Last G, Penrose M (2017) Lectures on the Poisson Process. Cambridge University Press"},{"key":"ref31","volume-title":"Computer methods for mathematical computations","author":"Forsythe GE","year":"1977","unstructured":"Forsythe GE, Malcolm MA, Moler CB (1977) Computer methods for mathematical computations. Prentice-Hall)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1137\/S1052623496303470","article-title":"Convergence properties of the Nelder-Mead simplex method in low dimensions","volume":"9","author":"Lagarias JC","year":"1998","unstructured":"Lagarias JC, Reeds JA, Wright MH, Wright PE (1998) Convergence properties of the Nelder-Mead simplex method in low dimensions. Siam J Optimiz 9:112\u2013147. 10.1137\/S1052623496303470","journal-title":"Siam J Optimiz"},{"key":"ref33","volume-title":"Algorithms for minimization without derivatives","author":"Brent RP","year":"1972","unstructured":"Brent RP (1972) Algorithms for minimization without derivatives. Prentice-Hall)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1074\/mcp.M116.061440","article-title":"An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant Pathways","volume":"16","author":"Jung SY","year":"2017","unstructured":"Jung SY, Choi JM, Rousseaux MW, Malovannaya A, Kim JJ, Kutzera J, Wang Y, Huang Y, Zhu W, Maity S et al (2017) An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant Pathways. Mol Cell Proteom 16:581\u2013593. 10.1074\/mcp.M116.061440","journal-title":"Mol Cell Proteom"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85214","author":"Yu Y","year":"2024","unstructured":"Yu Y, Gao SM, Guan Y, Hu PW, Zhang Q, Liu J, Jing B, Zhao Q, Sabatini DM, Abu-Remaileh M et al (2024) Organelle proteomic profiling reveals lysosomal heterogeneity in association with longevity. Elife 13. 10.7554\/eLife.85214"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1074\/mcp.TIR118.000850","article-title":"gpGrouper: A Peptide Grouping Algorithm for Gene-Centric Inference and Quantitation of Bottom-Up Proteomics Data","volume":"17","author":"Saltzman AB","year":"2018","unstructured":"Saltzman AB, Leng M, Bhatt B, Singh P, Chan DW, Dobrolecki L, Chandrasekaran H, Choi JM, Jain A, Jung SY et al (2018) gpGrouper: A Peptide Grouping Algorithm for Gene-Centric Inference and Quantitation of Bottom-Up Proteomics Data. Mol Cell Proteom 17:2270\u20132283. 10.1074\/mcp.TIR118.000850","journal-title":"Mol Cell Proteom"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"103645","DOI":"10.1016\/j.jprot.2020.103645","article-title":"Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects","volume":"217","author":"Mindikoglu AL","year":"2020","unstructured":"Mindikoglu AL, Abdulsada MM, Jain A, Choi JM, Jalal PK, Devaraj S, Mezzari MP, Petrosino JF, Opekun AR, Jung SY (2020) Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects. J Proteom 217:103645. 10.1016\/j.jprot.2020.103645","journal-title":"J Proteom"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1101\/gr.6202607","article-title":"A systems biology approach for pathway level analysis","volume":"17","author":"Draghici S","year":"2007","unstructured":"Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R (2007) A systems biology approach for pathway level analysis. Genome Res 17:1537\u20131545. 10.1101\/gr.6202607","journal-title":"Genome Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"pkz019","DOI":"10.1093\/jncics\/pkz019","article-title":"Methionine-Homocysteine Pathway in African-American Prostate Cancer","volume":"3","author":"Gohlke JH","year":"2019","unstructured":"Gohlke JH, Lloyd SM, Basu S, Putluri V, Vareed SK, Rasaily U, Piyarathna DWB, Fuentes H, Rajendiran TM, Dorsey TH et al (2019) Methionine-Homocysteine Pathway in African-American Prostate Cancer. JNCI Cancer Spectr 3:pkz019. 10.1093\/jncics\/pkz019","journal-title":"JNCI Cancer Spectr"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1158\/0008-5472.CAN-11-1154","article-title":"Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression","volume":"71","author":"Putluri N","year":"2011","unstructured":"Putluri N, Shojaie A, Vasu VT, Vareed SK, Nalluri S, Putluri V, Thangjam GS, Panzitt K, Tallman CT, Butler C et al (2011) Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. Cancer Res 71:7376\u20137386. 10.1158\/0008-5472.CAN-11-1154","journal-title":"Cancer Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1158\/1078\u2009\u2013\u20090432.CCR-18-1515","article-title":"Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer","volume":"25","author":"Vantaku V","year":"2019","unstructured":"Vantaku V, Dong J, Ambati CR, Perera D, Donepudi SR, Amara CS, Putluri V, Ravi SS, Robertson MJ, Piyarathna DWB et al (2019) Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer. Clin Cancer Res 25:3689\u20133701. 10.1158\/1078\u2009\u2013\u20090432.CCR-18-1515","journal-title":"Clin Cancer Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/HJH.0000000000003423","article-title":"Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites","volume":"41","author":"Chakraborty S","year":"2023","unstructured":"Chakraborty S, Lulla A, Cheng X, Yeo JY, Mandal J, Yang T, Mei X, Saha P, Golonka RM, Yeoh BS et al (2023) Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites. J Hypertens 41:979\u2013994. 10.1097\/HJH.0000000000003423","journal-title":"J Hypertens"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1038\/s41388-019-0902-7","article-title":"Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression","volume":"39","author":"Vantaku V","year":"2020","unstructured":"Vantaku V, Putluri V, Bader DA, Maity S, Ma J, Arnold JM, Rajapakshe K, Donepudi SR, von Rundstedt FC, Devarakonda V et al (2020) Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene 39:6265\u20136285. 10.1038\/s41388-019-0902-7","journal-title":"Oncogene"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3994376\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3994376\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T16:19:42Z","timestamp":1712765982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3994376\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":43,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3994376\/v1","relation":{},"subject":[],"published":{"date-parts":[[2024,4,10]]},"subtype":"preprint"}}